ReviewWomen's health (London, England)
Artificial intelligence in maternal and child health: Current applications, translational gaps, and future research priorities.
Review in Women's health (London, England). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) is rapidly transforming healthcare, with growing impact on maternal and child health (MCH) through advances in machine learning, deep learning, computer vision, generative models, and conversational systems. This article provides a comprehensive synthesis of current AI applications in MCH, structured across six key domains: predictive modeling, image analysis, deep learning and interpretability, generative and multi-omics approaches, conversational AI, and environmental and lifestyle analytics. Drawing on recent literature and the translational experience of the Spanish RICORS-SAMID network, we analyze how these technologies are being integrated into clinical, preventive, and assistive workflows. Across domains, AI demonstrates strong potential for early risk prediction (e.g., preeclampsia, fetal growth restriction, neonatal outcomes), automated image interpretation, biomarker discovery, and personalized decision support. However, despite promising performance metrics, most systems remain at the proof-of-concept stage, with limited external validation, scarce prospective evaluation, and incomplete integration into real-world clinical pathways. Key translational gaps include data heterogeneity, lack of interoperability, insufficient explainability, and challenges related to bias, fairness, and regulatory compliance. We argue that the next phase of AI in MCH must shift from static prediction toward longitudinal, mechanism-aware, and clinically actionable systems, supported by robust validation and multidisciplinary collaboration. Particular emphasis is placed on equity, as the benefits of AI must extend to low-resource settings where maternal and neonatal morbidity remains highest. By bridging technical innovation with clinical implementation, coordinated research networks such as RICORS can play a critical role in accelerating the safe, effective, and equitable deployment of AI in maternal and child healthcare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.